Skip to main content
Loading market data...
ETF Nasdaq USD

JPMorgan Healthcare Leaders ETF JDOC

Issuer: JPMorgan SEC registrant: J.P. Morgan Exchange-Traded Fund Trust Equity · Global
Watch JDOC (sign in) Add to portfolio (JDOC) Set an alert for JDOC Compare JDOC with other ETFs Position size calculator for JDOC at 62.7 USD

How position sizing works
Last price 62.70 USD Change: Up +0.62 Percent change: Up +1.00%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.65%
Prospectus 1 Mar 2026
Net assets
$9.1M
As of 31 Jul 2026
Holdings
61
As of 31 Jul 2026
12-month distribution yield
0.82%
Twice a year
Asset class
Equity
From holdings

JPMorgan Healthcare Leaders ETF (JDOC) is an exchange-traded fund listed on the Nasdaq in the United States, issued by JPMorgan. Its category is Equity · Global (equity). Its last price was US$62.70 on 20 Oct 2026. Its expense ratio is 0.65% a year, from its prospectus dated 1 Mar 2026. It reported net assets of US$9.07 million as of 31 Jul 2026. Its latest holdings report lists 61 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.51 a unit, a 12-month distribution yield of 0.82%, paid twice a year.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.65%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.65%
Prospectus date
1 Mar 2026
Filed with the SEC
30 Apr 2026

Source: SEC prospectus risk/return data sets (opens in a new tab) Filed

Size and reporting

Net assets
$9,074,769
Total assets
$9,189,729
Holdings as of
31 Jul 2026
Report made public
28 Sep 2026 (59 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Source: SEC Form N-PORT (opens in a new tab) Filed

Top holdings

Largest 25 of 61 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.

JDOC top holdings as of 31 Jul 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 AbbVie, Inc. US00287Y1091 7.85% $712K Equity (common) United States USD
2 Eli Lilly & Co. US5324571083 7.76% $704K Equity (common) United States USD
3 UnitedHealth Group, Inc. US91324P1021 5.85% $531K Equity (common) United States USD
4 Merck & Co., Inc. US58933Y1055 4.82% $437K Equity (common) United States USD
5 Johnson & Johnson US4781601046 4.82% $437K Equity (common) United States USD
6 AstraZeneca plc GB0009895292 3.76% $341K Equity (common) United Kingdom GBP
7 Thermo Fisher Scientific, Inc. US8835561023 3.73% $339K Equity (common) United States USD
8 Bristol-Myers Squibb Co. US1101221083 3.57% $324K Equity (common) United States USD
9 Abbott Laboratories US0028241000 3.11% $282K Equity (common) United States USD
10 CVS Health Corp. US1266501006 2.83% $257K Equity (common) United States USD
11 Roche Holding AG CH1499059983 2.82% $256K Equity (common) Switzerland CHF
12 Novo Nordisk A/S Novo Nordisk A/S, Class B DK0062498333 2.61% $237K Equity (common) Denmark DKK
13 GSK plc GB00BN7SWP63 2.47% $224K Equity (common) United Kingdom GBP
14 Stryker Corp. US8636671013 2.23% $202K Equity (common) United States USD
15 Danaher Corp. US2358511028 2.16% $196K Equity (common) United States USD
16 Cencora, Inc. US03073E1055 2.07% $188K Equity (common) United States USD
17 Argenx SE NL0010832176 2.06% $187K Equity (common) Netherlands EUR
18 Intuitive Surgical, Inc. US46120E6023 1.93% $175K Equity (common) United States USD
19 Edwards Lifesciences Corp. US28176E1082 1.73% $157K Equity (common) United States USD
20 IQVIA Holdings, Inc. US46266C1053 1.71% $155K Equity (common) United States USD
21 Teva Pharmaceutical Industries Ltd. IL0006290147 1.60% $145K Equity (common) Israel ILS
22 Regeneron Pharmaceuticals, Inc. US75886F1075 1.60% $145K Equity (common) United States USD
23 Novartis AG Novartis AG (Registered) CH0012005267 1.60% $145K Equity (common) Switzerland CHF
24 Biogen, Inc. US09062X1037 1.56% $142K Equity (common) United States USD
25 Cardinal Health, Inc. US14149Y1082 1.51% $137K Equity (common) United States USD

Source: SEC Form N-PORT (opens in a new tab) Made public Holdings as of 31 Jul 2026

All 61 stored holdings

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 99.20%
Short-term investment vehicles (cash funds) <0.01%

Country

Country by weight
CountryWeightBar
United States 75.20%
United Kingdom 6.23%
Switzerland 4.42%
Denmark 4.03%
Japan 2.47%
Netherlands 2.36%
Germany 1.86%
Israel 1.60%
Cayman Islands 0.69%
Ireland 0.35%
Not stated or supranational 0.00%

The country each issuer is assigned to in the report.

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 76.82%
British pound (GBP) 6.23%
Swiss franc (CHF) 4.42%
Euro (EUR) 4.22%
Danish krone (DKK) 3.45%
Japanese yen (JPY) 2.47%
Israeli shekel (ILS) 1.60%

The currency each holding is denominated in. Currency hedges are not netted off, so a hedged fund still shows its holdings' currencies.

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 61.67%
Industrials 5.90%
Consumer Staples 2.83%

Partial coverage: sectors are known for 70.4% of net assets (71% of the fund's equity weight), the holdings matched by CUSIP or ticker to US stocks listed on this site. The rest is not assigned a sector.

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.5120
1 payment per unit
12-month yield
0.82%
Distributions only, not total return
Frequency
Twice a year
From the gaps between ex-dates
Latest ex-date
16 Dec 2025

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.5120) ÷ latest price ($62.70) × 100 = 0.82%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (4 payments)
JDOC distributions per unit by ex-date
Ex-dateAmount per unit
16 Dec 2025$0.5120
24 Dec 2024$0.3280
16 Dec 2024$2.4890
19 Dec 2023$0.0800

Source: Yahoo Finance (opens in a new tab) Checked · 2 days ago Amounts are adjusted for later unit splits

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources
    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Region and currency: automatic

    Prices stay in each listing's own currency. Your currency is used for totals and for "≈" estimates at the daily reference rate. How this works

    Colour theme